Biotech to commence first-in-human clinical tria
Author: Michael
Another setback for aging-focused drug developme
Precision medicine player harnesses unique genet
Study targeting telomeres in progeria models hig
Study to focus on asymptomatic individuals with
Petr Šrámek on the evolution of longevity clin
Prestigious list acknowledges Sehgal’s work in
Startup leverages biological proximity to target
In conversation with Joanna Bensz, Peter Diamand
Clinical interventions for diagnosed aging disea